NasdaqGS:AGIOBiotechs
Agios Pharmaceuticals (AGIO) Could Be 8% Below Fair Value On Growth Index Shift
Index reshuffle puts Agios Pharmaceuticals in the growth spotlight
Agios Pharmaceuticals (AGIO) has shifted index buckets, dropping from the Russell 2000 Value-Defensive and Defensive indices while being added to several Russell growth benchmarks on 27 June 2026.
This reclassification places Agios Pharmaceuticals alongside companies screened for growth characteristics across the Russell 2000 Growth, Russell 3000 Growth, Russell 3000E Growth, Russell 2500 Growth, and Russell Small Cap Comp...